Indivior director granted 6,518 RSUs

Indivior Pharmaceuticals, Inc. reported that director Daniel A. Ninivaggi acquired 6,518 shares of common stock through a grant of Restricted Stock Units (RSUs).

Rhea-AI Filing Summary

Indivior Pharmaceuticals, Inc. reported that director Daniel A. Ninivaggi acquired 6,518 shares of common stock through a grant of Restricted Stock Units (RSUs). Each RSU represents the right to receive one share of common stock at vesting.

The RSUs vest on the day immediately preceding the company’s next annual stockholder meeting, subject to his continued service. Following this equity award, Ninivaggi directly owns 27,163 shares of Indivior common stock, reflecting a routine compensation-related increase in his holdings rather than an open‑market purchase.

Insider Trade Summary

Grant/Award: 6,518 shares

Grant/Award 1 txn

Insider NINIVAGGI DANIEL A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	6,518	$0.00	$0.00

Holdings After Transaction: Common Stock — 27,163 shares (Direct)

Footnotes (1)

1. F1. Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Key Figures

RSUs granted: 6,518 shares Shares owned after grant: 27,163 shares Transaction date: 2026-05-13 +1 more

4 metrics

RSUs granted 6,518 shares Restricted Stock Units award to director Daniel A. Ninivaggi

Shares owned after grant 27,163 shares Total direct Indivior common stock holdings post‑transaction

Transaction date 2026-05-13 Date of RSU grant reported on Form 4

Price per share $0.0000 RSUs granted as compensation with no cash exercise price

Key Terms

Restricted Stock Units (RSUs), contingent right, vest, continued service

4 terms

Restricted Stock Units (RSUs) financial

"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

contingent right financial

"Each RSU represents a contingent right to receive one share of the Issuer's common stock"

vest financial

"The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

continued service financial

"subject to the Reporting Person's continued service to the Issuer on the vesting date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Indivior (INDV) disclose about Daniel Ninivaggi’s latest equity grant?

Indivior disclosed that director Daniel A. Ninivaggi received a grant of 6,518 Restricted Stock Units (RSUs). Each RSU gives him a right to one share of common stock upon vesting, increasing his direct ownership stake through compensation rather than open‑market buying.

How many Indivior (INDV) shares does Daniel Ninivaggi hold after this Form 4?

After the RSU grant, Daniel A. Ninivaggi directly holds 27,163 shares of Indivior common stock. This figure includes the newly awarded 6,518 shares that were granted as equity compensation, as reflected in the Form 4 insider ownership totals.

What are the vesting terms of Daniel Ninivaggi’s Indivior RSU grant?

The 6,518 RSUs granted to Daniel A. Ninivaggi vest on the day immediately preceding Indivior’s next annual stockholder meeting. Vesting is conditioned on his continued service to the company through that vesting date, aligning the award with ongoing board service.

Does Daniel Ninivaggi’s Indivior Form 4 show a stock purchase or sale?

The Form 4 does not show an open‑market purchase or sale. It reports an “A” code transaction, meaning a grant or award acquisition of 6,518 RSUs at no cash price, which is standard equity compensation rather than a discretionary trade in Indivior shares.

What does an “A” transaction code mean in Indivior’s Form 4 for Daniel Ninivaggi?

The “A” code on Daniel A. Ninivaggi’s Form 4 indicates a grant, award, or other acquisition of securities. In this case, it reflects a compensation grant of 6,518 RSUs, not an open‑market buy, and therefore represents routine director equity compensation at Indivior.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/14/2026 - 04:10 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

NINIVAGGI DANIEL A

(Last) (First) (Middle)

10710 MIDLOTHIAN TURNPIKE

SUITE 125

(Street)

NORTH CHESTERFIELD VIRGINIA 23235

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Indivior Pharmaceuticals, Inc. [ INDV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/13/2026		A		6,518(1)	A	$0	27,163	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Remarks:

	/s/Alice Givens, Power of Attorney	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)